Loss of CD20 expression following rituximab-combined chemotherapy in CD20-positive and CyclinD1-positive multiple myeloma

[Rinshō ketsueki] The Japanese journal of clinical hematology

Volumn 49, Issue 11, 2008, Pages 1536-1540

  Shiratori, Souichi ^a   Kondo, Takeshi ^a   Kubota, Kanako ^a   Wakasa, Kentarou ^a   Ibata, Makoto ^a   Shono, Yusuke ^a   Takahata, Mutsumi ^a   Shigematu, Akio ^a   Kato, Naoko ^a   Ota, Shuichi ^a   Tanaka, Junji ^a   Matsuno, Yoshihiro ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CCND1 PROTEIN, HUMAN; CD20 ANTIGEN; CYCLIN D1; MONOCLONAL ANTIBODY; RITUXIMAB; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; CYCLIN D1; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 58149460544     PISSN: 04851439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)